Am J Nurs. 2021 Oct 1;121(10):51. doi: 10.1097/01.NAJ.0000794260.18402.18.
According to this study: Patients with immune-mediated disease who received biologic infusions at home were more likely to be admitted to the ED or hospital that day or the next compared with patients who received infusions at a facility.The safety implications of biologic home infusions need to be further evaluated.
与在医疗机构接受输注的患者相比,在家中接受生物制剂输注的免疫介导性疾病患者更有可能在当天或次日被收入急诊部或住院部。需要进一步评估生物制剂家庭输注的安全性。